Anti-viral compounds
US9163017B2 · kind B2 · utility
60Cited by
21References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2013 |
| Grant date | Oct 20, 2015 |
| Priority date | — |
| Expiry date | Sep 9, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.